Illumina Files 8-K for Regulation FD Disclosure
Ticker: ILMN · Form: 8-K · Filed: Apr 12, 2024 · CIK: 1110803
| Field | Detail |
|---|---|
| Company | Illumina, INC. (ILMN) |
| Form Type | 8-K |
| Filed Date | Apr 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $1 b |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
Related Tickers: ILMN
TL;DR
Illumina dropped an 8-K, likely a Reg FD disclosure. Check for news.
AI Summary
On April 12, 2024, Illumina, Inc. filed an 8-K report. The filing primarily concerns a Regulation FD Disclosure, indicating that the company is providing material information to the public. No specific financial transactions or material events beyond this disclosure are detailed in the provided text.
Why It Matters
This filing signifies that Illumina is making a public disclosure of information, which could be material to investors. Investors should review the full filing for details on the nature of the disclosure.
Risk Assessment
Risk Level: low — The filing is a standard regulatory disclosure and does not, in itself, indicate any immediate financial or operational risks.
Key Players & Entities
- Illumina, Inc. (company) — Registrant
- April 12, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to serve as a Regulation FD Disclosure, indicating that Illumina, Inc. is making material information publicly available.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is April 12, 2024.
What is Illumina, Inc.'s principal executive office address?
Illumina, Inc.'s principal executive office is located at 5200 Illumina Way, San Diego, CA 92122.
What is Illumina, Inc.'s telephone number?
Illumina, Inc.'s telephone number is (858) 202-4500.
Under which section of the Securities Exchange Act is this report filed?
This Current Report is filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 713 words · 3 min read · ~2 pages · Grade level 13.9 · Accepted 2024-04-12 09:01:14
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value ILMN The NASDAQ Global Select
- $1 b — t of such funding will be approximately $1 billion, which includes cash from GRAIL's
Filing Documents
- ilmn-20240412.htm (8-K) — 24KB
- ilmn-20240412_g1.jpg (GRAPHIC) — 7KB
- 0001110803-24-000013.txt ( ) — 162KB
- ilmn-20240412.xsd (EX-101.SCH) — 2KB
- ilmn-20240412_lab.xml (EX-101.LAB) — 21KB
- ilmn-20240412_pre.xml (EX-101.PRE) — 12KB
- ilmn-20240412_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Illumina, Inc. (the "Company") was notified today that the European Commission (the "EC") has formally approved the Company's divestment plan with respect to GRAIL, LLC (the "Divestment Plan"), which had been submitted to the EC pursuant to the EC's October 12, 2023, divestment order. Pursuant to the Divestment Plan, the Company may continue to concurrently explore both a trade sale and a capital markets divestiture. In the instance of a capital markets transaction, Illumina must capitalize GRAIL at the time of transaction with two-and-a-half years of funding based on GRAIL's long-range plan. The Company expects the amount of such funding will be approximately $1 billion, which includes cash from GRAIL's balance sheet, and reaffirms its goal of finalizing the terms of the divestiture by the end of the second quarter of 2024. Cautionary Note on Forward-Looking Statements This release may contain forward-looking statements that involve risks and uncertainties. Among the important factors to which our business is subject that could cause actual results to differ materially from those in any forward-looking statements are: (i) our ability to timely execute a strategic alternative that maximizes the value of GRAIL to our stockholders given the parameters required by the divestment order; (ii) the risk that the final amount of funding required to capitalize GRAIL may differ materially from our current expectations, together with other factors detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We undertake no obligation, and do not intend, to update these forward-looking statements, to review or confirm analysts' expectations, or to provide interim reports or updates on the progress of the current quarter. The information furnished pursuant to this Ite
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ILLUMINA, INC. Date: April 12, 2024 By: /s/ CHARLES DADSWELL Name: Charles Dadswell Title: General Counsel and Secretary